Personalis (PSNL) Files Patent Infringement Lawsuit Against Foresight Diagnostics

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. SPOT
6. WCN
7. FIX
8. BE
9. AXP
10. NDAQ

Go back to Personalis (PSNL) Files Patent Infringement Lawsuit Against Foresight Diagnostics

Personalis Files Patent Infringement Lawsuit Against Foresight Diagnostics

August 2, 2022 4:10 PM EDT

MENLO PARK, Calif.--(BUSINESS WIRE)-- Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, announced today that it filed a lawsuit against Foresight Diagnostics Inc. for infringement of Personalis U.S. Patent Nos. 10,450,611, 11,299,783, and 11,384,394. These patents are part of Personalis intellectual property portfolio in the field of whole genome-enabled, tumor-informed molecular residual disease (MRD) testing.

Personalis patent portfolio protects its pioneering work in whole genome sequencing to identify mutations that indicate the continued presence or recurrence of cancer with part-per-million sensitivity. Personalis is seeking both injunctive relief and monetary damages... More